Category: pharmacological
Aliases: Priligy
SSRI purpose-engineered for short half-life (~90 min initial; ~19 h terminal but minor). Designed to get out fast enough for on-demand use without the chronic-SSRI side effect + withdrawal burden. Not approved in US (NDA withdrawn 2004).
PO: 1.4h